H-RPPIFIRRL-OH

Ref. 3D-PH00432

Product Information

• Name: H-RPPIFIRRL-OH
• Synonyms: H-Arg-Pro-Pro-Ile-Phe-Ile-Arg-Arg-Leu-acid CEF31, Epstein - Barr Virus latent NA - 3A (379 - 387)

Description

Peptide H-RPPIFIRRL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-RPPIFIRRL-OH include the following: ERAP1 and ERAP2 Haplotypes Influence Suboptimal HLA-B* 27: 05-Restricted Anti-Viral CD8+ T Cell Responses Cross-Reactive to Self-Epitopes V Tedeschi , G Paldino, J Alba, E Molteni- International Journal of ..., 2023 - mdpi.comhttps://www.mdpi.com/1422-0067/24/17/13335 HLA-B27 and Ankylosing Spondylitis: functional aspects of HLA-B27 molecules and other factors involved in the disease pathogenesis V TEDESCHI - 2015 - iris.uniroma1.ithttps://iris.uniroma1.it/handle/11573/877043 Identification of immunodominant HLA-B7-restricted CD8+ cytotoxic T cell epitopes derived from mammaglobin-A expressed on human breast cancers H Ilias Basha, V Tiriveedhi , TP Fleming - Breast cancer research ..., 2011 - Springerhttps://link.springer.com/article/10.1007/s10549-010-0975-z Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis MP Pender , PA Csurhes , A Lenarczyk- Journal of Neurology ..., 2009 - jnnp.bmj.comhttps://jnnp.bmj.com/content/80/5/498.short Analysis of the conservation of T cell receptor alpha and beta chain variable regions gene in pp65 peptide-specific HLA-A* 0201-restricted CD8+ T cells W Luo, L Ma, Q Wen , M Zhou, X Wang - Cellular & Molecular ..., 2009 - nature.comhttps://www.nature.com/articles/cmi200914 Lack of immune responses against multiple sclerosis-”associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis K Ruprecht , F Gronen, M Sauter, B Best- Journal of ..., 2008 - Springerhttps://link.springer.com/article/10.1080/13550280801958922 A modified peptide stimulation method for efficient amplification of cytomegalovirus (CMV)-specific CTLs G Ruan, L Ma, Q Wen , W Luo, M Zhou- Cellular & Molecular ..., 2008 - nature.comhttps://www.nature.com/articles/cmi200824 Quantifying capsid peptide: MHC I complexes following adeno-associated virus (AAV) transduction GC Pien, NC Hasbrouck, MV Maus , F Mingozzi- 2007 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/110/11/3737/58226 Differential usage of cellular niches by cytomegalovirus versus EBV-and influenza virus-specific CD8+ T cells EMM Van Leeuwen, JJ Koning- The Journal of ..., 2006 - journals.aai.orghttps://journals.aai.org/jimmunol/article/177/8/4998/44604 Improved preparation of class I HLA tetramers and their use in detecting CMV-specific CTL GP Ruan, L Ma, MJ Meng, Y Zhu, ZH Chen- Journal of ..., 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022175906000779 Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls F Gronen, K Ruprecht , B Weissbrich, E Klinker- Journal of ..., 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S016557280600333X IL-7 receptor α chain expression distinguishes functional subsets of virus-specific human CD8+ T cells EMM van Leeuwen, GJ de Bree, EBM Remmerswaal - Blood, 2005 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/106/6/2091/21618 Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung GJ de Bree, EMM van Leeuwen, TA Out- The Journal of ..., 2005 - rupress.orghttps://rupress.org/jem/article-abstract/202/10/1433/52783 Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells R Vescovini, A Telera, FF Fagnoni, C Biasini- Experimental ..., 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0531556504001743 Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection B Savoldo , MH Huls, Z Liu, T Okamura- Blood, The Journal ..., 2002 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/100/12/4059/88286 MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells MS Staege, SP Lee , T Frisan - Proceedings of the ..., 2002 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.072495599 A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers LC Tan, N Gudgeon , NE Annels- The Journal of ..., 1999 - journals.aai.orghttps://journals.aai.org/jimmunol/article/162/3/1827/31986 A Re-Evaluation of the Frequency of CD8+ T Cells Specific for EBV in Healthy Virus Carriers1 N Annels, P Hansasuta , C O'Callaghan- 1999 - academia.eduhttps://www.academia.edu/download/51036081/A_re-evaluation_of_the_frequency_of_CD8_20161223-23619-13dy5fb.pdf Characterization of two Epstein-Barr virus epitopes restricted by HLA-B7 A Hill, A Worth , T Elliott- European journal of ..., 1995 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830250105

• Brand: Biosynth